1. Home
  2. CING vs DLPN Comparison

CING vs DLPN Comparison

Compare CING & DLPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CING
  • DLPN
  • Stock Information
  • Founded
  • CING 2012
  • DLPN N/A
  • Country
  • CING United States
  • DLPN United States
  • Employees
  • CING N/A
  • DLPN N/A
  • Industry
  • CING Biotechnology: Pharmaceutical Preparations
  • DLPN Other Consumer Services
  • Sector
  • CING Health Care
  • DLPN Consumer Discretionary
  • Exchange
  • CING Nasdaq
  • DLPN Nasdaq
  • Market Cap
  • CING 13.5M
  • DLPN 12.9M
  • IPO Year
  • CING 2021
  • DLPN N/A
  • Fundamental
  • Price
  • CING $4.10
  • DLPN $1.11
  • Analyst Decision
  • CING Strong Buy
  • DLPN Strong Buy
  • Analyst Count
  • CING 3
  • DLPN 1
  • Target Price
  • CING $96.00
  • DLPN $5.00
  • AVG Volume (30 Days)
  • CING 92.0K
  • DLPN 49.8K
  • Earning Date
  • CING 11-07-2024
  • DLPN 11-14-2024
  • Dividend Yield
  • CING N/A
  • DLPN N/A
  • EPS Growth
  • CING N/A
  • DLPN N/A
  • EPS
  • CING N/A
  • DLPN N/A
  • Revenue
  • CING N/A
  • DLPN $51,389,626.00
  • Revenue This Year
  • CING N/A
  • DLPN $21.74
  • Revenue Next Year
  • CING N/A
  • DLPN $7.26
  • P/E Ratio
  • CING N/A
  • DLPN N/A
  • Revenue Growth
  • CING N/A
  • DLPN 21.66
  • 52 Week Low
  • CING $1.80
  • DLPN $0.95
  • 52 Week High
  • CING $152.40
  • DLPN $3.58
  • Technical
  • Relative Strength Index (RSI)
  • CING 41.97
  • DLPN 45.36
  • Support Level
  • CING $4.09
  • DLPN $1.02
  • Resistance Level
  • CING $4.39
  • DLPN $1.20
  • Average True Range (ATR)
  • CING 0.20
  • DLPN 0.09
  • MACD
  • CING -0.02
  • DLPN -0.00
  • Stochastic Oscillator
  • CING 0.22
  • DLPN 26.47

About CING Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.

About DLPN Dolphin Entertainment Inc.

Dolphin Entertainment Inc is an independent entertainment marketing and production company. It provides strategic marketing and publicity services to many of the top brands, both individual and corporate, in the motion picture, television, music, gaming, culinary, hospitality, and lifestyle industries. It operates in two reportable segments: Entertainment publicity and marketing and Content production. It generates the majority of its revenue from the Entertainment publicity and marketing segment which provides clients with diversified marketing services, including public relations, entertainment and hospitality content marketing, strategic marketing consulting, and content production of marketing materials.

Share on Social Networks: